APA (7th ed.) Citation

AU, O., A, P., H, K., E, A., B, E., M, K., . . . E, H. (2026). Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022. Pituitary, 29(3), . https://doi.org/10.1007/s11102-026-01691-9

Chicago Style (17th ed.) Citation

AU, Ozkahraman, Pekmezci A, Karatay H, Akpinar E, Erkan B, Karagulle M, Kocak B, Niyazoglu M, and Hatipoglu E. "Clinicopathological Features and Outcomes of Immature PIT-1 Lineage Tumors: A High-risk Pituitary Neuroendocrine Tumor/pituitary Adenoma Subtype Per WHO 2022." Pituitary 29, no. 3 (2026). https://doi.org/10.1007/s11102-026-01691-9.

MLA (9th ed.) Citation

AU, Ozkahraman, et al. "Clinicopathological Features and Outcomes of Immature PIT-1 Lineage Tumors: A High-risk Pituitary Neuroendocrine Tumor/pituitary Adenoma Subtype Per WHO 2022." Pituitary, vol. 29, no. 3, 2026, https://doi.org/10.1007/s11102-026-01691-9.